在甲基胺使用障碍中针对神经炎症的治疗向
Natasha Jeffery1, Phooi Yan Mock1, Kun Yang2
1Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Future medicinal chemistry
|December 27, 2024
概括
本综述探讨了针对神经炎症治疗甲基胺使用障碍 (MUDs) 的目标. 专注于像托尔类受体4 (TLR4) 和NLRP3炎症体这样的点可能会减少METH诱导的大脑损伤并改善结果.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 甲基胺 (METH) 是一种危险的精神兴奋剂,与高死亡率有关.
- 甲使用障碍 (MUD) 与显著的神经炎症和神经损伤有关.
- 神经炎症有助于MUD的认知障碍和神经退行.
研究的目的:
- 审查MUD中神经炎症的潜在药物点.
- 检查托尔类受体4 (TLR4) 和NLRP3炎症体作为治疗点的作用.
- 评估针对神经炎症治疗MUD治疗的潜力.
主要方法:
- 关于METH,神经炎症和治疗点的当前研究的文献综述.
- 对专注于TLR4和NLRP3炎症酶通路的研究进行分析.
- 关于神经炎症对METH诱导的神经缺陷的影响的综合发现.
主要成果:
- 准神经炎症在缓解METH诱导的认知障碍和神经退行方面显示出有前途.
- TLR4和NLRP3炎症酶是管理METH诱导的神经炎症的关键点.
- 解决神经炎症可能会改善MUD患者的行为结果.
结论:
- 针对神经炎症是MUD的有前途的治疗策略.
- 对组合疗法和新型药物输送系统的进一步研究是有必要的.
- 开发神经保护剂对于有效的MUD干预至关重要.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
162
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
162
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Alzheimer's Disease: Treatment
162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162
Attention-Deficit/Hyperactivity Disorder
38
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
38
Drug Abuse and Addiction: Pharmacological Phenomena
434
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
434


